Most Recent

image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.

6 Comments

image: Fraction of SNPs Can Affect Fitness

Fraction of SNPs Can Affect Fitness

By | January 21, 2015

A point mutation analysis of the entire human genome finds that alterations to as many as 7.5 percent of nucleotides may have contributed to humans’ evolutionary split from chimpanzees.

1 Comment

image: Tracking Tuberculosis Over Time

Tracking Tuberculosis Over Time

By | January 19, 2015

Genomic analysis of a multidrug-resistant lineage pinpoints historical correlations with human events.

0 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

image: Genome Digest

Genome Digest

By | January 12, 2015

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Corn Chronicle

Corn Chronicle

By | January 8, 2015

A genetic analysis of ancient and modern maize clarifies the crop’s checkered domestication history.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: 23andMe, Genentech Partner on Parkinson’s

23andMe, Genentech Partner on Parkinson’s

By | January 7, 2015

Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.

0 Comments

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. National Academies Detail the State of Weed Science
  3. Neural Mechanism Links Alcohol Consumption to Binge Eating
  4. Image of the Day: Monkey Business
    Image of the Day Image of the Day: Monkey Business

    For the first time, researchers have documented interspecies sexual behavior between a male Japanese macaque and a female sika deer.

RayBiotech